Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer

Clinical trial NCT00016107 · COMPLETED

Trial details

NCT number: NCT00016107
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2001-06-01
Primary completion: 2007-02-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.